Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

106
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
106
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

65
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Human Genetics01:28

Human Genetics

1.8K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.8K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

159
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
159

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impacts of Vehicle Emission Regulations and Local Congestion Policies on Birth Outcomes Associated with Traffic Air Pollution.

Research report (Health Effects Institute)·2025
Same author

"Important but risky": attitudes of global thought leaders towards cost and value research in health professions education.

Advances in health sciences education : theory and practice·2022
Same author

AMEE Guide No. 123 - How to read studies of educational costs.

Medical teacher·2019
Same author

Prevalence of Parkinson's disease across North America.

NPJ Parkinson's disease·2018
Same author

Audit of ten years of donation after circulatory death experience in Queensland: observations of agonal physiology following withdrawal of cardiorespiratory support.

Anaesthesia and intensive care·2018
Same author

Response to commentary on passive smoking and Parkinson's disease in California teachers.

Parkinsonism & related disorders·2018

Related Experiment Video

Updated: Mar 21, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.0K

Common Genetic Variant Association with Altered HLA Expression, Synergy with Pyrethroid Exposure, and Risk for

G T Kannarkat1, D A Cook1, J-K Lee1

  • 1Department of Physiology, Emory University School of Medicine, Atlanta, GA.

NPJ Parkinson'S Disease
|May 6, 2016
PubMed
Summary

A common Parkinson's disease (PD) genetic variant (rs3129882) increases immune cell molecule expression. This variant, combined with pyrethroid insecticide exposure, significantly elevates PD risk, highlighting a gene-environment interaction.

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

16.3K

Related Experiment Videos

Last Updated: Mar 21, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

8.0K
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

35.0K
Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

16.3K

Area of Science:

  • Immunogenetics
  • Neuroimmunology
  • Environmental Health

Background:

  • The single nucleotide polymorphism (SNP) rs3129882 in the HLA-DRA gene, located in the major histocompatibility complex class II (MHC-II) locus, is linked to idiopathic Parkinson's disease (PD) risk.
  • Its position suggests a role for antigen presentation regulation in immune responses connecting genetic predisposition and environmental factors to PD.
  • Understanding this interplay is crucial for elucidating PD pathogenesis.

Purpose of the Study:

  • To investigate the functional impact of the rs3129882 SNP on MHC class II expression in immune cells.
  • To examine the interaction between this SNP and pesticide exposure in the context of Parkinson's disease risk.
  • To identify potential mechanisms underlying genetic susceptibility to PD.

Main Methods:

  • Immunophenotyping of blood cells from 81 subjects using quantitative reverse transcription PCR (qRT-PCR) and flow cytometry.
  • A case-control study involving 962 subjects to assess the association between pesticide exposure, the rs3129882 SNP, and PD risk.

Main Results:

  • Homozygosity for the 'G' allele at rs3129882 was associated with increased baseline and inducible expression of MHC class II molecules in B cells and monocytes.
  • Exposure to pyrethroid insecticides interacted synergistically with the risk conferred by the rs3129882 SNP (Odds Ratio = 2.48, p = 0.007).
  • This identified a novel gene-environment interaction contributing to PD risk through altered immune responses.

Conclusions:

  • The MHC-II locus may confer PD susceptibility by presenting pathogenic antigens or promoting pro-inflammatory CD4+ T cell responses.
  • Genetic or epigenetic modulation of MHC-II gene expression, potentially influenced by environmental factors like pyrethroids, could underlie this increased susceptibility.
  • These findings offer insights into the immunopathogenesis of Parkinson's disease.